Abstract: A system for repairing aircraft structures comprises a frame that is divided into two portions, and one or more straps that attach both portions of the frame to each other. A method of repairing includes the step of making a cutout in the skin of the structure to be repaired; dividing the frame into two portions; placing the two portions of the frame on the internal side of the skin through the cutout; and attaching the two portions of the frame to each other by one or more straps.

Abstract: The present invention relates to a non-human animal model of chronic glaucoma. In addition, the invention refers to a method for the preparation of said animal model, as well as to the use thereof.

Abstract: A two-way valve having a central body with a first end and a second end, the central body has a first internal valve and a second internal valve, the first internal valve enables the passage of a fluid along a first internal path only in the direction that goes from the second end to the first end of the central body, when a first fluid pressure threshold is exceeded, and the second internal valve enables the passage of a fluid along a second internal path only in the direction that goes from the first end to the second end of the central body, when a second fluid pressure threshold is exceeded, characterized in that a first axis of symmetry of the first internal path and a second axis of symmetry of the second internal path are parallel to each other and parallel to a longitudinal axis of the central body.

Abstract: Embodiments of the invention provide a solid food product, made with a fat free binder and a method of making. The binder includes a starch, an edible polyhydric alcohol, and a gum. In some embodiments, the food product is bouillon.

Abstract: Embodiments of the invention provide a fat free food product and method of making. In some embodiments, the food product is bouillon. The fat free food product is anhydrous, and contains a protein and a zero-fat binder. The binder includes a starch, an edible polyhydric alcohol, and a gum. The fat free food product has a protein content of 1.15% to 4.5% w/w. The food product contains no added fat.

Abstract: A cross device may include a bottom wall, a first sidewall being pivotably connected to the bottom wall, a second sidewall being pivotably connected to the bottom wall, a third sidewall being pivotably connected to the bottom wall, a fourth sidewall being pivotably connected to the bottom wall, and a top wall being pivotably connected to the first sidewall. The cross device may be movable between a first position in the form of a cross and a second position in the form of a rectangle.

Abstract: A cross device may include a bottom wall, a first sidewall being pivotably connected to the bottom wall, a second sidewall being pivotably connected to the bottom wall, a third sidewall being pivotably connected to the bottom wall, a fourth sidewall being pivotably connected to the bottom wall, and a top wall being pivotably connected to the first sidewall. The cross device may be movable between a first position in the form of a cross and a second position in the form of a rectangle.

Abstract: A container for a food product includes a wrapper which surrounds a frame. The container can be any polygonal shape which is defined by the shape of the frame. The wrapper forms a top of the container which has an access opening. A sealing cover is adhesively sealed to the top around the opening. The sealing cover is operable to expose the access opening and reclosable against the top to seal the access opening. The sealing cover, adhesive and top surface are optimized to provide sealing characteristics of sufficiently resealing frequency, relatively low noise level during unsealing and desirable peel forces to separate the seal between the sealing cover and the top.

Abstract: This system comprises a central unit (1) responsible for controlling the system and to which are connected: an intercom unit (2), an electronic learning unit (3), a consumption management unit (4), a receiver link unit (5), a simulation unit (6) which reproduces facial images with voice through a plasma display or screen, a push button unit (7), a telephone management unit (8) and an emitter and receiver volume control unit (9).

Abstract: The present invention relates to the use of 2-hydroxy or 2-acetyloxy-4-trifluoromethylbenzoic acid, respectively, for the treatment or prevention of mild cognitive impairment (MCI) in mammals, especially in human beings. Futhermore, the present invention also concerns the use of 2-hydroxy or 2-acetyloxy-4-trifluoromethylbenzoic acid, respectively, for delaying or preventing the conversion of MCI into dementia, especially Alzheimer's Disease.

Abstract: Neurodegenerative diseases, such as dementia, including Alzheimer's disease, can be treated or prevented by administering an effective amount of triflusal or its metabolite, or a pharmaceutically acceptable salt or a prodrug thereof.

Abstract: Neurodegenerative diseases, such as dementia, including Alzheimer's disease, can be treated or prevented by administering an effective amount of triflusal or its metabolite, or a pharmaceutically acceptable salt or a prodrug thereof.

Abstract: A method for inhibiting the activation of transcription factor NF-&kgr;B in a warm-blooded animal in need thereof, comprises administering to said animal an effective amount of a compound of formula I wherein R represents hydrogen or COCH3, or a pharmaceutically acceptable salt or a prodrug thereof.

Abstract: The invention relates to the use of 2-hydroxy-4-trifluoromethylbenzoic acid derivatives as inhibitors of the activation of the nuclear transcription factor NF-&kgr;B. The invention also relates to the utilization of 2-hydroxy-4-trifluoromethylbenzoic acid derivatives for the preparation of medicaments to treat or prevent of pathologies associated to the activation of NF-&kgr;B and/or the expression of genes which are dependent on or regulated by, at least partially, NF&kgr;B in mammals, including humans.

Abstract: Compounds of formula I and their salts and solvates are useful for the treatment or prevention of inflammatory bowel disease. Pharmaceutical compositions including these compounds and processes for their preparation are also provided.

Abstract: The present invention relates to 8-chloro-11-[1-[(5-methyl-3-pyridyl)methyl]-4-piperidyliden]-6,11-dihydro- 5H-benzo[5,6]cyclohepta[1,2-b]pyridine, to a process for its preparation and to pharmaceutical compositions containing it. This compound is a dual PAF antagonist and antihistamine.

Abstract: The present invention relates to 8-chloro-11-[1-[(5-methyl-3-pyridyl)methyl]-4-piperidyliden]-6,11-dihydro- 5H-benzo[5,6]cyclohepta[1,2-b]pyridine, to a process for its preparation and to pharmaceutical compositions containing it. This compound is a dual PAF antagonist and antihistamine.